Clinical Trial Update: A Study of BV-AVD in People With Bulky Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BV-AVD in patients with bulky Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• Adriamycin (doxorubicin)
• DTIC-Dome (dacarbazine)
• Velban (vinblastine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hodgkin Lymphoma | Phase 2 | Status: RECRUITING